Zobrazeno 1 - 10
of 181
pro vyhledávání: '"A. F. DAVYDOVA"'
Autor:
A. E. Karateev, E. S. Filatova, E. Yu. Pogozheva, V. N. Amirdzhanova, E. L. Nasonov, A. M. Lila, V. I. Mazurov, A. Yu. De, A. A. Baranov, N. A. Lapkina, G. V. Lukina, N. A. Kiryukhina, S. Yu. Davidyan, T. S. Salnikova, R. R. Samigullina, D. S. Chakieva, I. M. Marusenko, O. V. Semagina, M. Yu. Semchenkova, A. F. Davydova, E. V. Kalinina
Publikováno v:
Современная ревматология, Vol 14, Iss 2, Pp 69-75 (2020)
Janus kinase (JK) inhibitors block the intracellular signaling pathways that are responsible for the synthesis of proinflammatory cytokines and mediators, which in turn cause the activation of pain receptors and central sensitization (CS). It is sugg
Externí odkaz:
https://doaj.org/article/af84c1d6e4e34c688e41f9ab87acd8f6
Autor:
A. E. Karateev, E. Yu. Pogozheva, V. N. Amirjanova, E. S. Filatova, A. M. Lila, V. I. Mazurov, R. R. Samigullina, A. M. Dadalova, A. Yu. Dyo, D. S. Chakieva, A. A. Baranov, N. A. Lapkina, E. N. Koltsova, N. A. Kiryukhina, I. N. Shchendrigin, T. G. Rasevich, A. F. Davydova, I. V. Semizarova, I. A. Shafieva, I. B. Bashkova, D. A. Bobrikova, D. A. Murtazalieva, I. N. Kushnir, E. V. Kalinina, T. S. Salnikova, I. M. Marusenko, O. V. Semagina, I. B. Vinogradova, D. G. Krechikova, M. Yu. Semchenkova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 4 (2021)
The JAK inhibitor tofacitinib (TOFA) blocks the intracellular signaling pathway that activates the synthesis of cytokines and mediators involved in the development of pain and central sensitization (CS), which determines the rapid analgesic effect. H
Externí odkaz:
https://doaj.org/article/f878a9466c984864885b3baf4937c75e
Publikováno v:
Научно-практическая ревматология, Vol 57, Iss 4, Pp 478-481 (2019)
The diagnosis of a disease accompanied by febrile syndrome presents special problems in clinical practice. The traditional diagnostic algorithm in this case involves the exclusion of infections, cancer, and rheumatic diseases. The causes of fever can
Externí odkaz:
https://doaj.org/article/b5a452def25740719ec9e4b6cb01063c
Autor:
A E Karateev, E Yu Pogozheva, E A Filatova, V N Amirjanova, A M Lila, O V Antipova, A R Babaeva, A V Volkorezova, A F Davydova, V G Davtyan, E V Zonova, O N Ivanova, N N Kalinina, N I Kiseleva, L A Knyazeva, A I Kulikov, O B Nesmeyanova, V I Mazurov, L V Masneva, L V Menshikova, I V Obuhova, E N Otteva, T S Salnikova, I N Shchendrygin, S P Yakupova
Publikováno v:
Терапевтический архив, Vol 90, Iss 6, Pp 65-73 (2018)
Non-steroidal anti-inflammatory drugs (NSAIDs) are most popular medications for the treatment of pain in common musculoskeletal diseases such as osteoarthritis (OA) and non-specific low back pain (LBP). However, the factors affecting the effectivenes
Externí odkaz:
https://doaj.org/article/e4a273b8b13b4eb68d62beba2d567eb5
Publikováno v:
Кубанский научный медицинский вестник, Vol 25, Iss 1, Pp 88-93 (2018)
Aim. To study the features of renal arterial blood flow in patients suffering from rheumatoid arthritis, its interaction with visual markers of atherosclerosis in the presence of comorbid hypertension.Materials and methods. 113 patients with rheumato
Externí odkaz:
https://doaj.org/article/4a04bd91b773495b929174bb2122f013
Publikováno v:
South Russian Journal of Therapeutic Practice. 3:70-76
Objective: to test the patented “Method for determining a high risk of atherosclerosis in rheumatoid arthritis” on patients with rheumatoid arthritis.Materials and methods: 74 patients with RA who underwent inpatient treatment were examined. Gend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a755c81ea88a994678e0ceff5d61fb7
https://doi.org/10.21886/2712-8156-2022-3-4-70-76
https://doi.org/10.21886/2712-8156-2022-3-4-70-76
Autor:
E. L. Nasonov, V. I. Mazurov, E. V. Zonova, L. A. Knyazeva, I. M. Marusenko, O. B. Nesmeyanova, T. V. Plaksina, Yu. S. Shapovalova, E. P. Ilivanova, D. G. Krechikova, N. A. Petrochenkova, O. V. Reshetko, L. N. Denisov, I. G. Gordeev, A. F. Davydova, N. A. Eremina, E. V. Zemerova, T. B. Ivanova, A. A. Kastanayan, T. G. Pokrovskaya, S. A. Smakotina, E. A. Smolyarchuk, A. V. Artemyeva, R. A. Ivanov, Yu. V. Usacheva, E. V. Chernyaeva
Publikováno v:
Научно-практическая ревматология, Vol 55, Iss 4, Pp 351-359 (2017)
The Russian biotechnological company «BIOCAD» has designed a chimeric monoclonal antibody against CD20 (BCD-020, Acellbia®) that is a biosimilar of rituximab (RTM; MabThera®, F. Hoffmann-La Roche Ltd., Switzerland). In recent years, there has bee
Externí odkaz:
https://doaj.org/article/b1c240855964421db5640cb92522328f
Autor:
L I Alekseeva, G S Arkhangelskaya, A F Davydova, E A Karmiltseva, К М Kogan, V I Mazurov, A P Rebrov, O F Ryabitseva, T G Shemerovskaya, S S Yakushin, V A Nasonova, D G Soldatov
Publikováno v:
Терапевтический архив, Vol 78, Iss 9, Pp 82-86 (2003)
Aim. To evaluate duration of a clinical response to the drug structum in patients with osteoarthrosis (OA) of the knee and hip joints as well as structum effects on OA course and that of concomitant diseases. Material and methods. The duration of a c
Externí odkaz:
https://doaj.org/article/f2dd9ee88dcc4eefbba4757b56c5423e
Autor:
V A Nassonova, L I Alexeyeva, G S Arkhangelskaya, A. F. Davydova, E A Karmiltzeva, K M Kogan, V I Mazurov, A P Rebrov, O F Ryabitzeva, T G Shemerovskaya, S. S. Yakushin
Publikováno v:
Научно-практическая ревматология, Vol 39, Iss 2, Pp 46-51 (2001)
Objective. Study of the efficacy and tolerability of Structum in pts with gonarthritis and coxarthritis during 6 months therapy. Material. Open multicentral study included off -patients of both sexes with osteoarthritis (ОЛ) of knee and hip joints
Externí odkaz:
https://doaj.org/article/ac8ed7fdc18144a698a8d53d5a4766c9
Publikováno v:
Научно-практическая ревматология, Vol 43, Iss 3 (2005)
Externí odkaz:
https://doaj.org/article/83c4d5bc9277482c816692a8bca7f9ad